CDT Equity CDT
NASDAQ CDT
$2.86 -0.04 (-1.38%)
At close: Aug 21, 2026 · 4:00 PM EDT

CDT Equity (CDT) Net Equity Issued and Repurchased (2022 - 2025)

CDT Equity's (CDT) quarterly Net Equity Issued and Repurchased came in at $1.7 million in Q4 2025, down 4.65% YoY from $1.8 million in Q4 2024, and down 70.99% on a QoQ basis from $6.0 million in Q3 2025.

CDT Equity (CDT) Net Equity Issued and Repurchased (2022 - 2025) Analysis & Trends

CDT Equity (CDT) has 4 years of Net Equity Issued and Repurchased data on file, last reported at $1.7 million in Q4 2025.

  • Quarterly Net Equity Issued and Repurchased fell 4.65% year-over-year to $1.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $19.7 million (changed N/A YoY) and the FY2025 annual result came in at $19.7 million, up 491.92% from the prior year.
  • Net Equity Issued and Repurchased retreated to $1.7 million in Q4 2025, from $6.0 million in the prior quarter.
  • In the past five years, Net Equity Issued and Repurchased ranged from a high of $8.1 million in Q1 2025 to a low of -$1000.0 in Q4 2023.
  • A 4-year average of $3.1 million and a median of $1.8 million in 2024 frame the typical range for Net Equity Issued and Repurchased.
  • Annual changes were most pronounced in 2023 — Net Equity Issued and Repurchased tumbled 100.2% — and 2024, when it soared 182900.0%.
  • Tracing CDT's Net Equity Issued and Repurchased over 4 years: stood at $511000.0 in 2022, then plunged by 100.2% to -$1000.0 in 2023, then soared by 182900.0% to $1.8 million in 2024, then decreased by 4.65% to $1.7 million in 2025.
  • The last three Net Equity Issued and Repurchased figures came in at $1.7 million (Q4 2025), $6.0 million (Q3 2025), and $3.9 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 49.20 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn -
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 CDT Equity 1.55 Mn 1.55 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 1.74 Mn
Dec 31, 2025 1.74 Mn
Sep 30, 2025 6.01 Mn
Sep 30, 2025 6.01 Mn
Jun 30, 2025 3.89 Mn
Jun 30, 2025 3.89 Mn
Mar 31, 2025 8.06 Mn
Mar 31, 2025 8.06 Mn
Dec 31, 2024 1.83 Mn
Dec 31, 2024 1.83 Mn
Dec 31, 2023 -1,000.00
Dec 31, 2023 -1,000.00
Dec 31, 2022 511,000.00
Dec 31, 2022 511,000.00